Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

05 December 2003

Methoxychlor modifies the ultradian secretory pattern of prolactin and affects its TRH response.

Anunciación A Lafuente1, Aníbal A González-Carracedo, Alejandro A Romero, Ana I AI Esquifino

Med Sci Monit 2003; 9(5): PI37-42 :: ID: 3300


Methoxychlor (MTX) is an insecticide characterized by both estrogenic and antiandrogenic properties that may modify the secretory pattern of prolactin. The objective of the present work was to analyze MTX's effects on changes in the episodic secretion of prolactin induced by thyrotropin-releasing hormone (TRH).
Adult male Sprague-Dawley rats (400-420 g body weight) were administered 25 or 50 mg/kg/day of MTX s.c. in sesame oil for 30 days. Control animals received the vehicle only.
In animals treated with 50 mg/kg/day of MTX, mean serum prolactin levels and absolute pulse amplitude increased (p< or = 0.05 and p< or = 0.001 respectively). TRH administration (two pulses of 2 Kg) increased both mean serum prolactin levels and the absolute amplitude of the prolactin peaks in all groups studied (p< or = 0.001). The response to TRH was greatly increased in the animals treated with 50 mg/kg/day. TRH reduced the mean life of the hormone in control rats (p< or = 0.01) and in animals treated with 50 mg/kg/day (p< or = 0.001). After TRH administration, the duration of prolactin peaks was increased in the MTX-treated animals (p< or = 0.05 and p< or = 0.001 for 25 and 50 mg/kg/day respectively). TRH reduced the frequency of prolactin pulses in the animals treated with 50 mg/kg/day (p< or = 0.05).
These data suggest that MTX sensitizes the pituitary to TRH, indicating a direct effect of MTX on the pituitary gland.

Keywords: Activity Cycles, Animals, Insecticides, Male, Methoxychlor, Pituitary Gland, prolactin, Rats, Rats, Sprague-Dawley, Thyrotropin-Releasing Hormone

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Clinical Research  

Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...

Med Sci Monit In Press; DOI: 10.12659/MSM.944222  

Clinical Research  

Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Di...

Med Sci Monit In Press; DOI: 10.12659/MSM.944116  

Database Analysis  

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma

Med Sci Monit In Press; DOI: 10.12659/MSM.943523  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750